Q32 Bio Inc.

NASDAQ:QTTB

Biotechnology

Healthcare
$8.48 -1.70%

-$0.22 today

Market cap
$253.75M
Beta
-0.23
P/E (TTM)
5.4
EPS (TTM)
$2.36
52W Low $1.35High $14.85

Volume 0.31M

Average 0.74M

Balance Sheet

Inspect the capital base behind the business.

Assets

$61.78M

FY 2025 · Annual

-33.1% YoY

Liabilities

$19.76M

FY 2025 · Annual

-77.2% YoY

Equity

$42.01M

FY 2025 · Annual

+640.3% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents108.38M43.89M25.62M77.97M48.3M
Short-term Investments47.49M0000
Net Receivables01.06M755K555K0
Inventory01.75M000
Other Current Assets36.04M146K83K396K6.75M
Total Current Assets191.91M46.85M28.72M81.88M55.05M
Property, Plant & Equipment (Net)17.86M9.17M8.08M7.09M6.08M
Goodwill00000
Intangible Assets00000
Long-term Investments1.95M25.81M5.65M2.6M647K
Tax Assets00000
Other Non-current Assets0(20.06M)10.26M763K0
Total Non-current Assets19.81M14.92M18.34M10.46M6.73M
Total Assets211.72M61.77M47.06M92.33M61.78M
Account Payables2.37M1.44M3.47M2.99M879K
Short-term Debt246K32.4M878K3.1M6.93M
Tax Payables0570K316K00
Deferred Revenue3.21M14.53M000
Other Current Liabilities11.41M2.79M3M5.68M3.54M
Total Current Liabilities17.23M57.87M14.11M16.47M11.35M
Long-term Debt05.07M43.18M9.56M3.47M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)1.16M11.32M000
Other Non-current Liabilities0111.45M166.45M55M0
Total Non-current Liabilities24.84M134.62M215.87M70.19M8.42M
Total Liabilities42.07M192.49M229.98M86.66M19.76M
Common Stock6K6K1K2K2K
Retained Earnings(424.13M)(429.14M)(187.08M)(234.81M)(204.99M)
Accumulated OCI(7K)(404K)000
Other Stockholders Equity00000
Minority Interest00000
Total Equity169.65M(130.71M)(182.92M)5.68M42.01M
Total Debt23.93M44.73M50.84M18.9M15.34M
Net Debt(84.45M)838K25.22M(59.06M)(32.95M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$50.8M
Other Current$6.5M
Total Current Assets$57.2M
PP&E (Net)$5.8M
Other Non-current$647.0K
Total Non-current Assets$6.5M
Total Assets$63.7M

Analysis

Selected assets total $63.7M for Latest. The largest visible component is Cash & Equivalents at $50.8M, about 79.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 6, 2026
SC 13G/ASC 13G/A filingNov 6, 2026
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
SC 13GSC 13G filingOct 28, 2026

How much cash does QTTB have?

Q32 Bio Inc. (QTTB) reported $48.30M in cash and equivalents in fiscal 2025.

How much debt does QTTB carry?

Q32 Bio Inc. (QTTB) reported $15.34M of total debt, with net debt of -$32.95M.